Ispire Malaysia Attains ISO Certification, Avoiding 25% Transportation Tariffs

Business by 2FIRSTS.ai

Jan.05.2024

Ispire Malaysia Attains ISO Certification, Avoiding 25% Transportation Tariffs

Ispire Malaysia obtains ISO certifications, CEO Michael Wang says having its own factory will increase profit margins.

According to an announcement on the official website of Ispire on January 4th, the company has declared that its Malaysian subsidiary, Ispire Malaysia Sdn Bhd, has successfully obtained certifications for ISO9001:2015 Quality Management System, ISO14001:2015 Environmental Management System, and ISO13485:2016 Medical Device Quality Management System for its manufacturing facility in Malaysia.

Michael Wang, the CEO of the company, stated that having our own factory will allow us to achieve greater profits in product assembly. Furthermore, the products produced by our company in Malaysia and shipped to the United States are not affected by tariffs, which creates favorable conditions for increasing gross profit margins.

Michael Wang stated, "We have received our initial orders and are rapidly entering the production preparation phase. By establishing production facilities in Malaysia, we not only avoid the 25% tariffs incurred from shipping from China, but also improve our gross profit margin."

In order to reduce tariff costs, it is predicted that Ispire will further shift its production processes to Malaysia.

References:

[1] 雾麻科技马来西亚制造设施获ISO认证

Also Read:

[1] E-cig Export Data from China to Malaysia, November 2023

[2] Apology for Exclusion: Public Health Tobacco Control Act 2023

[3] Malaysian Parliament Passes 2023 Public Health Control of Smoking Products Act

#Asia #Market #Regulation #Malaysia

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency

The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.

Dec.02 by 2FIRSTS.ai

KT&G Nears ASF Acquisition, Preparing Wide Regional Nicotine Pouch Expansion

South Korean outlet nate reports that KT&G expects to finalize its acquisition of Nordic nicotine pouch maker ASF within this year. Beginning next year, the company plans to expand the business well beyond ASF’s current five Nordic markets to Europe, the Middle East, Africa, Asia and North America, supported by its cooperation framework with Altria.

Nov.25

Product | Compatible with 3ml/2ml Pods and Up to 45W Output: RELX Launches a New Open-System E-Cigarette on Its Indonesia Website

RELX has launched the open-system RELX Prime Pro on its Indonesia website and has also rolled it out across multiple local e-commerce channels. According to publicly available product pages, the device is rated at up to 45W, features a 1350mAh battery, and is compatible with 3ml and 2ml pod capacities.

Dec.30 by 2FIRSTS.ai

Smoking Rate Drops to 17.9%, Vaping Rate Climbs to 9.3% in South Korea

The Korea Disease Control and Prevention Agency (KDCA) released its 2025 Community Health Survey results covering more than 230,000 adults. Traditional cigarette smoking dropped to 17.9%, down 1 percentage point from last year, while e-cigarette use increased to 9.3%, up 0.6 points. Overall tobacco product use stood at 22.1%, a slight decline from 2024 but still 0.5 points higher than 2019.